These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9683818

  • 1. E-cadherin but not N-cadherin expression is correlated with the intracellular distribution of catenins in human hepatocellular carcinomas.
    Nuruki K, Toyoyama H, Ueno S, Hamanoue M, Tanabe G, Aikou T, Ozawa M.
    Oncol Rep; 1998; 5(5):1109-14. PubMed ID: 9683818
    [Abstract] [Full Text] [Related]

  • 2. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
    Endo K, Ueda T, Ueyama J, Ohta T, Terada T.
    Hum Pathol; 2000 May; 31(5):558-65. PubMed ID: 10836294
    [Abstract] [Full Text] [Related]

  • 3. The reduced expression of e-cadherin, alpha-catenin and gamma-catenin but not beta-catenin in human lung cancer.
    Toyoyama H, Nuruki K, Ogawa H, Yanagi M, Matsumoto H, Nishijima H, Shimotakahara T, Aikou T, Ozawa M.
    Oncol Rep; 1999 May; 6(1):81-5. PubMed ID: 9864406
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
    Kim YT, Choi EK, Kim JW, Kim DK, Kim SH, Yang WI.
    Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
    [Abstract] [Full Text] [Related]

  • 6. Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma.
    Hao X, Palazzo JP, Ilyas M, Tomlinson I, Talbot IC.
    Anticancer Res; 1997 Dec; 17(3C):2241-7. PubMed ID: 9216695
    [Abstract] [Full Text] [Related]

  • 7. Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines.
    Mialhe A, Levacher G, Champelovier P, Martel V, Serres M, Knudsen K, Seigneurin D.
    J Urol; 2000 Sep; 164(3 Pt 1):826-35. PubMed ID: 10953163
    [Abstract] [Full Text] [Related]

  • 8. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
    Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL.
    J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.
    Shimazui T, Schalken JA, Giroldi LA, Jansen CF, Akaza H, Koiso K, Debruyne FM, Bringuier PP.
    Cancer Res; 1996 Sep 15; 56(18):4154-8. PubMed ID: 8797585
    [Abstract] [Full Text] [Related]

  • 10. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
    Papadavid E, Pignatelli M, Zakynthinos S, Krausz T, Chu AC.
    J Pathol; 2002 Feb 15; 196(2):154-62. PubMed ID: 11793366
    [Abstract] [Full Text] [Related]

  • 11. E-, N- and P-cadherin, and alpha-, beta- and gamma-catenin protein expression in normal, hyperplastic and carcinomatous human prostate.
    Arenas MI, Romo E, Royuela M, Fraile B, Paniagua R.
    Histochem J; 2000 Nov 15; 32(11):659-67. PubMed ID: 11272805
    [Abstract] [Full Text] [Related]

  • 12. Expression of E-cadherin, alpha, beta and gamma-catenin in human colorectal cancer.
    Hiscox S, Jiang WG.
    Anticancer Res; 1997 Nov 15; 17(2B):1349-54. PubMed ID: 9137497
    [Abstract] [Full Text] [Related]

  • 13. A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma.
    Chow V, Yuen AP, Lam KY, Tsao GS, Ho WK, Wei WI.
    J Cancer Res Clin Oncol; 2001 Jan 15; 127(1):59-63. PubMed ID: 11206273
    [Abstract] [Full Text] [Related]

  • 14. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions.
    Nakanishi Y, Ochiai A, Akimoto S, Kato H, Watanabe H, Tachimori Y, Yamamoto S, Hirohashi S.
    Oncology; 1997 Jan 15; 54(2):158-65. PubMed ID: 9075789
    [Abstract] [Full Text] [Related]

  • 15. Beta- and gamma-catenin expression in thyroid carcinomas.
    Cerrato A, Fulciniti F, Avallone A, Benincasa G, Palombini L, Grieco M.
    J Pathol; 1998 Jul 15; 185(3):267-72. PubMed ID: 9771480
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
    Rocha AS, Soares P, Seruca R, Máximo V, Matias-Guiu X, Cameselle-Teijeiro J, Sobrinho-Simões M.
    J Pathol; 2001 Jul 15; 194(3):358-66. PubMed ID: 11439369
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas.
    Zhai B, Yan HX, Liu SQ, Chen L, Wu MC, Wang HY.
    World J Gastroenterol; 2008 Oct 07; 14(37):5665-73. PubMed ID: 18837082
    [Abstract] [Full Text] [Related]

  • 20. Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors?
    Mialhe A, Louis J, Montlevier S, Peoch M, Pasquier D, Bosson JL, Rambeaud JJ, Seigneurin D.
    Invasion Metastasis; 1997 Oct 07; 17(3):124-37. PubMed ID: 9702939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.